First-Line Treatment for Sinusitis
Amoxicillin-clavulanate 875 mg/125 mg twice daily for 7-10 days is the preferred first-line antibiotic for acute bacterial sinusitis in adults, though antibiotics should only be started when bacterial infection is confirmed by specific clinical criteria. 1, 2
When to Start Antibiotics (Critical Decision Point)
Most acute rhinosinusitis (98-99.5%) is viral and resolves spontaneously within 7-10 days without antibiotics. 1 Antibiotics are indicated only when one of three patterns is present:
- Persistent symptoms: Nasal discharge or cough lasting ≥10 days without improvement 1, 2
- Severe symptoms: Fever ≥39°C with purulent nasal discharge for ≥3 consecutive days 1, 2
- "Double sickening": Worsening symptoms after initial improvement from a viral upper respiratory infection 1, 2
Do not prescribe antibiotics for symptoms lasting <10 days unless severe symptoms are present, as this contributes to antimicrobial resistance without clinical benefit. 1
First-Line Antibiotic Selection
Standard First-Line Choice
- Amoxicillin-clavulanate 875 mg/125 mg twice daily is preferred over plain amoxicillin due to increasing prevalence of β-lactamase-producing organisms (H. influenzae and M. catarrhalis). 1, 2
- Plain amoxicillin 500 mg twice daily (mild disease) or 875 mg twice daily (moderate disease) remains acceptable for uncomplicated cases without recent antibiotic exposure. 1, 2
- Treatment duration: 7-10 days, typically continuing until symptom-free for 7 days (total 10-14 days). 1, 2
For Penicillin-Allergic Patients
Classify the allergy type first to guide safe antibiotic selection. 1
- Non-anaphylactic reactions (rash, mild reactions): Second- or third-generation cephalosporins are safe and recommended. 1
- Severe Type I hypersensitivity (anaphylaxis): Respiratory fluoroquinolones (levofloxacin 500 mg once daily or moxifloxacin 400 mg once daily for 10 days) provide 90-92% predicted clinical efficacy. 1, 3
Avoid azithromycin and other macrolides as first-line therapy due to resistance rates of 20-25% for both S. pneumoniae and H. influenzae. 1
Symptomatic Treatment (Appropriate for All Patients)
For viral rhinosinusitis or while awaiting bacterial confirmation:
- Analgesics: Acetaminophen or NSAIDs for pain and fever relief 1, 4
- Intranasal corticosteroids: Reduce mucosal inflammation, alleviate symptoms, and potentially decrease need for antibiotics 1, 4
- Saline nasal irrigation: Provides symptomatic relief and promotes drainage 1, 4
- Oral decongestants: Symptomatic relief (pseudoephedrine) 1, 4
- Topical decongestants: Maximum 3 days use to prevent rhinitis medicamentosa (rebound congestion) 2, 4
Treatment Failure Protocol
Reassess at 3-5 days: If no improvement, switch antibiotics or re-evaluate diagnosis. 1, 2
- Switch to high-dose amoxicillin-clavulanate (4 g amoxicillin/250 mg clavulanate per day) for enhanced coverage against drug-resistant S. pneumoniae. 1
- Alternative: Respiratory fluoroquinolones (levofloxacin 500-750 mg once daily or moxifloxacin 400 mg once daily) for treatment failures, providing excellent coverage against multi-drug resistant organisms. 1, 3
Pediatric Dosing Considerations
- Standard therapy: Amoxicillin 45 mg/kg/day in 2 divided doses 1
- High-risk children (age <2 years, daycare attendance, recent antibiotic use, high local resistance): Amoxicillin 80-90 mg/kg/day in 2 divided doses OR amoxicillin-clavulanate 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 1
Critical Pitfalls to Avoid
- Inadequate treatment duration leads to relapse—complete the full 7-10 day course even after symptoms improve. 1, 2
- Reserve fluoroquinolones as second-line therapy to prevent resistance development; use only for complicated sinusitis, first-line treatment failure, or severe penicillin allergy. 1, 2
- Watchful waiting is appropriate for uncomplicated cases when follow-up can be assured—start antibiotics only if no improvement by 7 days or worsening at any time. 1
- Number needed to treat with antibiotics is 10-15 to get one additional person better after 7-15 days, emphasizing the importance of proper patient selection. 1